PR Newswire All News ReleasesQwen · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 16:03:00·⟳ 抓取 16:03:24 +24s·⚡ 决策 08-27 16:07:30 +4m06s·61.2 天前
DJS Law Group发布Capricor Therapeutics（CAPR）证券集体诉讼律师广告，与近3日已处理的同一诉讼完全重复
本条是DJS Law Group就同一证券集体诉讼发布的律师广告，与8月24-27日已处理的Hagens Berman、Levi & Korsinsky、BFA Law、Rosen Law Firm、Schall Brown & Schwartz等至少5条同一诉讼的记录完全重复。底层负面事实（Deramiocel统计分析计划修改未获FDA同意、PDUFA延至2026-11-22）早已公开，市场已消化（8/24-25 CAPR因FDA延期审评反而上涨）。本条无任何新增金额、指引修正、监管进展或官方确认/否认，不构成新催化。
📄 原文PR Newswire All News Releases↗ 原文
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAP…
不做 Capricor Therapeutics（CAPR.US）
本条是同一证券集体诉讼的第6次律师广告重复发布（8/24-27已有5家律所发布同一诉讼），无任何新增事实。底层负面（统计分析计划修改未获FDA同意）早已公开并定价；8/24-25 CAPR因FDA延期审评反而上涨。不构成新催化，无做空或做多edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
DJS Law Group的PR Newswire发布是关于Capricor Deramiocel统计分析计划修改的证券集体诉讼律师广告。案例库显示同一诉讼在8/24-8/27已被至少5家不同律所通过相同渠道反复发布，底层事实（修改统计计划未获FDA同意、BLA审评延至11/22）早已公开。8/24-25 CAPR因FDA延期审评消息反而上涨。本条无新增事实，属于同一催化的第6次重复传播，不构成可交易信号。
🔎 新鲜度:最早出现 2026-08-24 · 扩散 high · price-in 风险 high ↗
消息传播链
- 2026-08-24首发Schall Brown & Schwartz via PR Newswire声称一手 · 未核验同一诉讼最早可见的律师广告，围绕Deramiocel BLA统计分析计划修改征集投资者
- 2026-08-25行业媒体转载BFA Law / Rosen Law Firm via PR Newswire非一手第二、三家律所发布同一诉讼广告，无新增事实
- 2026-08-26行业媒体转载Levi & Korsinsky非一手第四家律所发布同一诉讼广告
- 2026-08-27 04:03 ET行业媒体转载Hagens Berman via PR Newswire非一手第五家律所发布同一诉讼广告，与本条同日发布
- 第六家律所发布同一诉讼广告，无任何新增事实
反向证据
- 做空前查反向 · 来源 web · 影响 invalidates
未找到7月CRL或近期暴跌证据；相反8/24-25 CAPR因FDA延期审评消息上涨，说明市场将延期解读为偏正面（给予更多审评时间而非拒绝）
检索:CAPR Capricor stock drop July 2026 CRL Deramiocel
先例如何影响了这次决策
对本次决策的影响:无先例影响最终决策；决策基于重复消息判断
方向:不适用——本条为已处理事件的重复传播，无需先例校准
涨幅量级:不适用
形态:不适用
工具调用 · 历史记录,结果未知(5 种)
- fetch_decision_experience · 结果未知
- search_processed_events · 结果未知
- stock_quote · 结果未知
- web_search · 结果未知
- search_case_library · 结果未知
原文全文
展开原文 · 2,208 字
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
LOS ANGELES, Aug. 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: December 17, 2025 to July 26, 2026
DEADLINE: September 28, 2026
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Capricor modified the statistical analysis plan used in the analysis of clinical data for Deramiocel. The Company failed to secure the FDA's agreement to this change before it resubmitted a Biologics License Application for the drug. Based on these facts, Capricor's public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. As one of the founding partners of Schall Brown & Schwartz LLP (schallfirm.com), David Schwartz specializes in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]
SOURCE DJS Law Group LLP
LOS ANGELES, Aug. 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: December 17, 2025 to July 26, 2026
DEADLINE: September 28, 2026
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Capricor modified the statistical analysis plan used in the analysis of clinical data for Deramiocel. The Company failed to secure the FDA's agreement to this change before it resubmitted a Biologics License Application for the drug. Based on these facts, Capricor's public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. As one of the founding partners of Schall Brown & Schwartz LLP (schallfirm.com), David Schwartz specializes in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]
SOURCE DJS Law Group LLP
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。